Stock Price
3.14
Daily Change
0.08 2.61%
Monthly
1.95%
Yearly
-7.37%
Q1 Forecast
2.86

OraSure Technologies reported $340.83M in Equity Capital and Reserves for its fiscal quarter ending in December of 2025.





Equity Capital And Reserves Change Date
Agilent USD 6.91B 167M Dec/2025
AngioDynamics USD 176.33M 2.52M Sep/2025
Becton, Dickinson and Co. USD 25.28B 108M Dec/2025
Bio Techne USD 2.01B 45.18M Dec/2025
Bio-Rad Laboratories USD 7.45B 716.8M Dec/2025
Bruker USD 2.49B 625.6M Sep/2025
Cerus USD 61.46M 6.04M Sep/2025
Charles River Laboratories USD 3.16B 240.82M Dec/2025
Danaher USD 52.53B 1.46B Dec/2025
Dentsply International USD 1.34B 139M Dec/2025
Dexcom USD 2.75B 19.9M Dec/2025
Hologic USD 5.25B 197.2M Dec/2025
Illumina USD 2.72B 342M Dec/2025
Integra LifeSciences USD 1.04B 5.89M Dec/2025
Intuitive Surgical USD 17.82B 894.3M Dec/2025
IQVIA Holdings USD 6.5B 343M Dec/2025
Mesa Laboratories USD 186.69M 8.22M Dec/2025
Mettler Toledo International USD -23.64M 225.56M Dec/2025
Myriad Genetics USD 368M 4.8M Dec/2025
OraSure Technologies USD 340.83M 21.15M Dec/2025
Quidel USD 1.92B 115.9M Dec/2025
Repligen USD 2.11B 1.66B Dec/2025
Revvity USD 7.38B 180.27M Sep/2025
STAAR Surgical USD 344.18M 9.6M Dec/2025
Thermo Fisher Scientific USD 53.54B 2.38B Dec/2025
Trinity Biotech USD -54.72M 5.18M Sep/2025
Waters USD 2.56B 230.55M Dec/2025